Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-26-059112
Filing Date
2026-05-19
Accepted
2026-05-19 17:08:29
Documents
85
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0290983-10q_oramed.htm   iXBRL 10-Q 947289
2 CERTIFICATION ea029098301ex31-1.htm EX-31.1 15976
3 CERTIFICATION ea029098301ex31-2.htm EX-31.2 15995
4 CERTIFICATION ea029098301ex32-1.htm EX-32.1 5763
5 CERTIFICATION ea029098301ex32-2.htm EX-32.2 5220
  Complete submission text file 0001213900-26-059112.txt   7113366

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ormp-20260331.xsd EX-101.SCH 77723
7 XBRL CALCULATION FILE ormp-20260331_cal.xml EX-101.CAL 48115
8 XBRL DEFINITION FILE ormp-20260331_def.xml EX-101.DEF 372641
9 XBRL LABEL FILE ormp-20260331_lab.xml EX-101.LAB 584390
10 XBRL PRESENTATION FILE ormp-20260331_pre.xml EX-101.PRE 381229
89 EXTRACTED XBRL INSTANCE DOCUMENT ea0290983-10q_oramed_htm.xml XML 899973
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 261000187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)